Several studies have shown a significant reduction of PPARγ expression in cancers such as colon cancer (210, 211), gastric cancers (212), follicular thyroid cancer (213), cervical carcinoma (214), and esophageal cancer (215) (Figure 3). The gene discussed is PPARG; the disease is colonic neoplasm.